E

EVA - the Basel start-up agency

10 employees

EVA is sparring partner for new entrepreneurs in the Life Sciences with planned base in north-western Switzerland.

Investor insights

Sectors invested in

Biotechnology5

Pharmaceutical3

Medical Device3

Communities2

Medical2

Nosocomial infections1

Tuberculosis1

Small molecules1

Antibiotic resistance1

Laser osteotomy1

Robotic surgery1

Medical Robotics1

single B cell1

Infectious disease1

Human antibodies1

Antibody repertoire1

Therapeutic antibodies1

Antibody discovery1

antibodyome1

High throughput1

Funding rounds participated in

$2.7M sweet spot round size

Most of their 7 investments are in rounds between $2.3M and $3.1M

Investor type

Venture Capital

Basic info

Industry

biotechnology research

Sectors

Biotechnology

Financial Services

Insurance

Banking

Consulting

Information Technology

Venture Capital

Date founded

1996

Investments made

P

Polyneuron Pharmaceuticals AG raised $3.1M on May 14, 2018

Investors: Zürcher Kantonalbank and EVA - the Basel start-up agency

P

Polyneuron Pharmaceuticals AG raised $3.1M on May 12, 2016

Investors: Zürcher Kantonalbank and EVA - the Basel start-up agency

I

Inthera Bioscience AG raised $3.7M on December 14, 2015

Investors: Novo Holdings and EVA - the Basel start-up agency

M

Memo Therapeutics AG raised $2.3M on July 22, 2015

Investors: Redalpine, Zürcher Kantonalbank and EVA - the Basel start-up agency

A

Advanced Osteotomy Tools AG (AOT AG) raised $1.7M on January 25, 2012

Investors: Zürcher Kantonalbank, StartAngels Network and EVA - the Basel start-up agency

B

BioVersys AG raised $2.7M on March 31, 2011

Investors: GoBeyond and EVA - the Basel start-up agency

U

Undisclosed raised $2.6M on February 1, 2005

Investors: VI Partners AG and EVA - the Basel start-up agency